A carregar...
Publicação
Johnson & Johnson equity research report: research industry & company valuation
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 589.01 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Johnson & Johnson, founded in 1886, is a global healthcare leader specializing in pharmaceuticals and medical devices, headquartered in the
United States. This report is part of equity research on Johnson & Johnson, and it aims to allow to have a deeper known of the company and his industry. Additionally, a multiples valuation is presented. The overall results of the valuation, taking into account the analysis done,
presents a BUY recommendation after obtained a target share price for FY26 of $244.86.
Descrição
Palavras-chave
Valuation Discounted cash flow WACC Johnson & Johnson Pharma